×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
JBIO – jade biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
JBIO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/8
06:15 am
jbio
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
1/7
07:18 am
jbio
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Low
Report
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
1/6
08:27 am
jbio
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
Low
Report
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
1/5
07:19 am
jbio
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:00 am
jbio
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
12/16
04:38 pm
jbio
Jade Biosciences (NASDAQ:JBIO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Jade Biosciences (NASDAQ:JBIO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
12/15
07:05 am
jbio
Jade Biosciences Announces $45 Million Private Placement [Yahoo! Finance]
Low
Report
Jade Biosciences Announces $45 Million Private Placement [Yahoo! Finance]
12/15
07:00 am
jbio
Jade Biosciences Announces $45 Million Private Placement
Low
Report
Jade Biosciences Announces $45 Million Private Placement
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/5
07:18 am
jbio
Form 8-K Jade Biosciences, Inc. For: Jan 05
Medium
Report
Form 8-K Jade Biosciences, Inc. For: Jan 05
12/31
06:04 am
jbio
Form EFFECT Jade Biosciences, Inc.
Low
Report
Form EFFECT Jade Biosciences, Inc.
12/30
04:01 pm
jbio
Form 424B3 Jade Biosciences, Inc.
Low
Report
Form 424B3 Jade Biosciences, Inc.
12/22
04:39 pm
jbio
Form S-1 Jade Biosciences, Inc.
Medium
Report
Form S-1 Jade Biosciences, Inc.
12/22
06:04 am
jbio
Form EFFECT Jade Biosciences, Inc.
Low
Report
Form EFFECT Jade Biosciences, Inc.
12/19
04:28 pm
jbio
Form 424B3 Jade Biosciences, Inc.
Low
Report
Form 424B3 Jade Biosciences, Inc.
12/15
07:11 am
jbio
Form 8-K Jade Biosciences, Inc. For: Dec 13
Low
Report
Form 8-K Jade Biosciences, Inc. For: Dec 13
11/14
04:36 pm
jbio
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
High
Report
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: